Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.95 USD | +1.86% |
|
+3.11% | -20.25% |
14/05 | Transcript : Bioceres Crop Solutions Corp., Q3 2024 Earnings Call, May 14, 2024 | |
14/05 | Bioceres Crop Solutions Fiscal Q3 Earnings, Revenue Fall | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The company's profit outlook over the next few years is a strong asset.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The company benefits from high valuations in earnings multiples.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-20.25% | 69Cr | - | ||
+11.94% | 3.74TCr | C | ||
-.--% | 1.17TCr | - | B+ | |
+21.33% | 780.46Cr | - | C- | |
-9.96% | 708.59Cr | A | ||
+9.80% | 685.47Cr | B- | ||
-10.51% | 562.26Cr | B+ | ||
-12.04% | 523.69Cr | B | ||
-4.00% | 512.55Cr | C+ | ||
+28.14% | 504.65Cr | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BIOX Stock
- Ratings Bioceres Crop Solutions Corp.